Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-on study of H1N1 antibody persistence and seasonal influenza vaccine response in children previously immunized with Celvapan or Pandemrix
2010-022817-24Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Oct 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of Fluarix and Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in influenza (2 arms), sponsored by University of Oxford. Started Oct 2010; status: completed.
02
Drugs
FluarixInfluenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
influenza
Beyond the preview
Go deeper on 2010-022817-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022817-24.